Skip to main content
Premium Trial:

Request an Annual Quote

Reinhard Schneider, David Fenyo, Gregory Kinch

Premium

Reinhard Schneider stepped down as CIO of Lion Bioscience last week “to pursue new challenges,” according to the company. Schneider is a founding member of the company. Prior to joining Lion, he held a position as a scientist at the European Molecular Biology Laboratory in Heidelberg, Germany. He will continue to act as a consultant to Lion, which “has reached a size that allows me to pursue new challenges in a more scientific environment,” Schneider said in a statement.

David Fenyo, founder and president of protein informatics firm ProteoMetrics, has joined Amersham Biosciences as a staff scientist. Fenyo most recently served as director of proteomics for Genomic Solutions after it acquired ProteoMetrics in Feb. 2002.

Silicon Genetics has appointed another Genomic Solutions alum, Gregory Kinch, to the position of vice president of sales and services. Kinch served as executive vice president of sales and marketing at Genomic Solutions, where he was responsible for acquiring, developing, and selling microarray and proteomics technologies.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.